Keyphrases
Angiostatic
33%
Anti-glioma
100%
Antitumor
33%
Antitumor Immune Response
33%
Brain Tumor
33%
Cancer Cells
33%
Clinical Efficacy
33%
Clinical Evaluation
33%
Clinical Practice
100%
Clinical Trials
66%
Cytotoxic Effect
33%
Genetically Modified Viruses
33%
Glioblastoma multiforme
33%
Glioma
33%
Glioma Microenvironment
33%
Glioma Patients
33%
Glioma Stem Cells
33%
Immune Response
33%
Immune Targeting
33%
Laboratory Results
66%
Malignant Glioma
100%
Mode of Delivery
33%
Oncolytic Virotherapy
100%
Poor Prognosis
33%
Preclinical Evaluation
33%
Recurring
33%
Therapeutic Approaches
66%
Treatment Options
33%
Vasculature
33%
Virotherapy
33%
Virus
66%
Medicine and Dentistry
Cancer Cell
16%
Clinical Trial
50%
Cytokine
16%
Cytotoxicity
16%
Ganglioglioma
100%
Glioblastoma
100%
Glioma Stem Cell
16%
Immune Response
33%
Intracranial Tumor
16%
Neoplasm
33%
Oncolytic Virotherapy
100%
Translating (Language)
100%
Vascularity
16%
Virotherapy
16%
Virus
50%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
75%
Cytokine
25%
Cytotoxicity
25%
Glioblastoma
100%
Intracranial Tumor
25%
Malignant Neoplasm
25%
Neoplasm
50%
Virotherapy
100%